LENSAR INC (LNSR)

Company Profile

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its systems, the LENSAR Laser System and ALLY Adaptive Cataract Treatment System incorporate a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device kit. The company has developed its ALLY Adaptive Cataract Treatment System (ALLY System). The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room.

Company Info

LENSAR INC

2800 Discovery Drive, Suite 100

Orlando FLORIDA 32826

P: 18885367271

CEO: Nicholas Curtis

Employees: 110

Website: https://www.lensar.com/